Eduardo Sabate
Eduardo Sabate
Unknown affiliation
Verified email at post.harvard.edu
Title
Cited by
Cited by
Year
Adherence to long-term therapies: evidence for action
World Health Organization
World Health Organization, 2003
49272003
Adherence to long-term therapies: evidence for action
E Sabaté, E Sabaté
World Health Organization, 2003
44402003
Adherence to long-term therapies: evidence for action
S De Geest, E Sabaté
European Journal of Cardiovascular Nursing 2 (4), 323-323, 2003
4752003
Adherence to long-term therapies: evidence for action
PV Burkhart, E Sabaté
Journal of nursing scholarship: an official publication of Sigma Theta Tau …, 2003
3282003
WHO adherence meeting report
E Sabate
Geneva: World Health Organization, 2001
1602001
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 …
D Stark, M Nankivell, E Pujade-Lauraine, G Kristensen, L Elit, M Stockler, ...
The lancet oncology 14 (3), 236-243, 2013
1552013
The challenge of chronic conditions: WHO responds: The sooner governments act, the better
JA Epping-Jordan, R Bengoa, R Kawar, E Sabaté
Bmj 323 (7319), 947-948, 2001
1522001
Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003
E Sabate
Google Scholar, 2016
1102016
Adherence to long-term therapies: policy for action: meeting report, 4-5 June 2001
E Sabaté, World Health Organization
World Health Organization, 2001
572001
World Bank Pharmaceuticals
R Govindaraj, MR Reich, JC Cohen
World Bank, Washington, DC, 2000
402000
Adherencia a los tratamientos a largo plazo
E Sabaté
Génova: organización Mundial de la Salud, 2004
362004
The magnitude of the problem of poor adherence
E Sabaté
Adherence to long-term therapies: evidence for action. Geneva: World Health …, 2003
182003
Adherence to long-term therapies management: a call for cardiovascular nursing managers and policymakers.
E Sabaté, S De Geest
Progress in cardiovascular nursing 19 (1), 28-29, 2004
172004
Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers
S De Castro, E Sabaté
Clinical infectious diseases 37 (Supplement_5), S464-S467, 2003
172003
Depression in young people and the elderly
E Sabaté
Priority medicines for Europe and the world “A public health approach to …, 2004
122004
Organización Mundial de la Salud
E Sabaté
Adherencia a los tratamientos a largo plazo: pruebas para la acción …, 2004
92004
Guidelines for epidemiological reviews: the Global Burden of Disease 2000 project
CD Mathers, E Sabaté, AD Lopez
Global Programme on Evidence for Health Policy World Health Organization, 2001
52001
Adherencia a los tratamientos a largo plazo: pruebas para la acción
World Health Organization
Organización Mundial de la Salud, 2004
42004
Costs of managing side effects in the treatment of first line metastatic renal cell carcinoma (mRCC) in Germany, France, and UK: Bevacizumab (BEV)+ interferon alpha-2a (IFN …
G Mickisch, BJ Escudier, ME Gore, S Walzer, E Sabaté, M Nuijten
Journal of Clinical Oncology 26 (15_suppl), 5110-5110, 2008
32008
Therapy adherence
M Smirnoff, NR Reynolds, E Sabate
AJN The American Journal of Nursing 104 (5), 15-16, 2004
32004
The system can't perform the operation now. Try again later.
Articles 1–20